Core Viewpoint - AstraZeneca shareholders have approved a direct listing of the company's shares on the New York Stock Exchange, which will provide access to a deeper capital pool [1] Group 1 - The approval from shareholders marks a significant step for AstraZeneca in enhancing its market presence [1] - The direct listing is expected to facilitate greater liquidity and attract a broader range of investors [1] - This move aligns with the trend of pharmaceutical companies seeking to optimize their capital structures through public listings [1]

Core Viewpoint - Cambridge Technology Co., Ltd. (剑桥科技) successfully listed on the Hong Kong Stock Exchange, closing at HKD 92.20, a 33.86% increase from its final offering price of HKD 68.88 [1][5]. Summary by Relevant Sections IPO Details - The total number of H-shares issued under the global offering is 67,010,500, with 6,701,050 shares allocated for the Hong Kong offering and 60,309,450 shares for international offering [1]. - The total proceeds from the offering amount to HKD 4,615.7 million, with net proceeds of HKD 4,480.0 million after deducting estimated listing expenses of HKD 135.7 million [5]. Use of Proceeds - Approximately 50% (HKD 2,240.0 million) of the net proceeds will be used to enhance the company's facilities and the capacity of current and future co-location partners [5]. - About 20% (HKD 896.0 million) will be allocated to further enhance R&D talent and technology [5]. - 5% (HKD 224.0 million) will be used for business promotion and marketing [5]. - 15% (HKD 672.0 million) is earmarked for overseas strategic investments [5]. - 10% (HKD 448.0 million) will be used for general corporate purposes, including working capital needs [5]. Key Investors - Major cornerstone investors include Baillie Gifford, Morgan Stanley Investment Partners, HCEP, and several others, with significant allocations of shares [3][4]. - Notable allocations include 3.37% for Baillie Gifford, Morgan Stanley, and HCEP, and 5.06% for Qidian Asset Management [4]. Company Overview - Cambridge Technology primarily engages in the design, development, and sale of connectivity and data transmission equipment, generating revenue mainly from broadband, wireless, and optical module technology products [6]. - The company is recognized as one of the few that provides all three types of technology products to global customers [6].

超颖电子电路股份有限公司 首次公开发行股票主板 上市公告书提示性公告 保荐人（主承销商）： 扫描二维码查阅公告全文 本公司及全体董事、监事、高级管理人员保证信息披露的内容真实、准 确、完整、及时，没有虚假记载、误导性陈述或重大遗漏。 经上海证券交易所审核同意，超颖电子电路股份有限公司（以下简称"本公 司"、"发行人"、"公司"、"超颖电子"）发行的人民币普通股股票将于 2025 年 10 月 24 日在上海证券交易所主板上市，上市公告书全文和首次公开发行股票 的招股说明书全文披露于上海证券交易所网站（http://www.sse.com.cn/）和符合 中国证监会规定条件网站（中证网：http://www.cs.com.cn；上海证券报网： http://www.cnstock.com；证券时报网：http://www.stcn.com；证券日报网： http://www.zqrb.cn；经济参考网：http://www.jjckb.cn；中国金融新闻网： https://www.financialnews.com.cn；中国日报网：https://cn.chinadaily.com.cn）披 露，并置备于发 ...

Core Viewpoint - Marco Polo announced that its stock will be listed on the Shenzhen Stock Exchange main board on October 22, 2025, under the stock name "Marco Polo" with the code 001386 [1] Summary by Relevant Sections - **Initial Public Offering (IPO) Details** - Total share capital after the IPO will be 1.195 billion shares, with 119 million shares being issued [1] - **Investor Warnings** - The company cautions investors about several risks, including the potential for increased volatility due to the lifting of price limits, the stock being eligible for margin trading on the first day of listing, a low number of circulating shares, speculative trading, differences in the issuance price-to-earnings ratio compared to industry peers, the possibility of the stock price falling below the issuance price, and a decline in return on equity [1]

Core Viewpoint - Jebang Technology (301326.SZ) reported a revenue of 438 million yuan for the first half of 2023, marking a year-on-year increase of 27.51%, but faced significant net losses [1][2]. Financial Performance - The company's revenue for the first half of 2023 was 437,563,581.36 yuan, up 27.51% from 343,161,782.76 yuan in the same period last year [2]. - The net profit attributable to shareholders was -38,023,569.68 yuan, a decline of 572.70% compared to -5,652,381.96 yuan in the previous year [2]. - The net profit after deducting non-recurring gains and losses was -42,653,207.11 yuan, representing a decrease of 195.19% from -14,449,608.02 yuan [2]. - The net cash flow from operating activities was -65,423,440.64 yuan, a drop of 537.21% from -10,267,235.33 yuan [2]. Future Projections - For 2024, the company is projected to achieve a revenue of 792,805,238.89 yuan, a 16.90% increase from 678,193,574.22 yuan in 2023 [3]. - The net profit attributable to shareholders is expected to improve to -19,348,460.60 yuan, a 65.33% reduction from -55,803,415.39 yuan in 2023 [3]. - The net profit after deducting non-recurring gains and losses is projected to be -33,129,566.38 yuan, a 53.10% improvement from -70,641,707.56 yuan [3]. - The net cash flow from operating activities is anticipated to be 20,799,161.98 yuan, a significant decrease of 85.85% from 146,987,913.70 yuan in 2023 [3]. IPO and Fundraising - Jebang Technology raised a total of 936.132 million yuan from its initial public offering, with a net amount of 836.9503 million yuan after deducting issuance costs [4]. - The final net fundraising amount exceeded the original plan by 28.69503 million yuan [4]. - The funds are intended for the construction of a high-precision electronic functional structural component production base, a research and development center, and to supplement working capital [4].

Core Viewpoint - AstraZeneca plans to switch to a direct listing of its shares in the United States to capitalize on the booming U.S. stock market [1] Group 1: Company Strategy - The company aims to maximize gains from the U.S. stock market through this direct listing approach [1]

Core Viewpoint - Zhenlei Technology (688270.SH) announced that its chairman, Yu Faxin, is currently under investigation by the Huangshi Municipal Supervisory Committee, but the company's control has not changed and normal operations will continue [1] Group 1: Company Governance and Management - The company has a robust governance structure and internal control mechanisms in place, ensuring that daily operations are managed by senior management during the chairman's absence [1] - Zhang Bing, a board member, will temporarily assume the chairman's responsibilities while Yu Faxin is unable to perform his duties [1] Group 2: Financial Performance - In the first half of 2025, Zhenlei Technology achieved a revenue of 205 million yuan, representing a year-on-year increase of 73.64% [2][3] - The net profit attributable to shareholders reached approximately 62.32 million yuan, marking a significant year-on-year growth of 1006.99% [2][3] - The net profit after deducting non-recurring gains and losses was approximately 52.89 million yuan, a recovery from a loss of 605,600 yuan in the same period last year [2][3] - The net cash flow from operating activities was approximately 10.21 million yuan, compared to a negative cash flow of 4.31 million yuan in the previous year [3] Group 3: Historical Financial Data - Over the past five years, Zhenlei Technology's revenue has shown consistent growth, with figures of 152.1 million yuan, 190.6 million yuan, 242.6 million yuan, 280.8 million yuan, and 303.4 million yuan respectively [3] - The net profit attributable to shareholders over the same period has varied, with figures of 76.94 million yuan, 98.84 million yuan, 107.7 million yuan, 72.48 million yuan, and 17.85 million yuan [3] Group 4: Initial Public Offering (IPO) Details - Zhenlei Technology was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on January 27, 2022, with an issue price of 61.88 yuan per share and a total issuance of 27.31 million shares [4] - The total funds raised from the IPO amounted to 1.69 billion yuan, with a net amount of 1.54 billion yuan after deducting issuance costs [4] Group 5: Stock Dividend and Bonus Issues - On May 26, 2023, the company announced a stock bonus plan of 4 additional shares for every 10 shares held, along with a pre-tax dividend of 3 yuan [5] - A similar plan was announced on May 9, 2024, proposing 4 additional shares for every 10 shares held and a pre-tax dividend of 1.7 yuan [6]

上海友升铝业股份有限公司 首次公开发行股票主板 上市公告书提示性公告 保荐人（主承销商）：国泰海通证券股份有限公司 扫描二维码查阅公告全文 本公司及全体董事、监事、高级管理人员保证信息披露的内容真实、准确、 完整、及时，没有虚假记载、误导性陈述或重大遗漏。 经上海证券交易所（以下简称"上交所"）审核同意，上海友升铝业股份有 限公司（以下简称"友升股份""发行人"或"公司"）人民币普通股股票将于 2025 年 9 月 23 日在上交所主板上市，上市公告书全文和首次公开发行股票的招股 说明书全文披露于上交所网站（http://www.sse.com.cn）和符合中国证券监督管理 委 员 会规定条件 的 网 站 （ 中 国 证 券 网 ，www.cnstock.com；中证网， www.cs.com.cn；证券时报网，www.stcn.com；证券日报网，www.zqrb.cn；经济参 考网，网址 www.jjckb.cn），并置备于发行人、上交所、本次发行保荐人（主承 销商）国泰海通证券股份有限公司的住所，供投资者查阅。 一、上市概况 （五）首次公开发行股票数量：4,826.7111 万股，本次发行全部为新股，无 ...

Core Points - Jiangyin Huaxin Precision Technology Co., Ltd. (referred to as "Huaxin Precision" or "the Company") will be listed on the Shanghai Stock Exchange main board on September 5, 2025, with a total share capital of 174.95 million shares after the IPO [2] - The IPO involves the issuance of 43.74 million new shares, with no existing shares being transferred [2] - The stock code for Huaxin Precision is 603370, and the initial public offering price is set at 18.60 yuan per share [2] Listing Overview - Stock abbreviation: Huaxin Precision [2] - Total shares after IPO: 174.95 million shares [2] - Number of shares issued in the IPO: 43.74 million shares, all new shares [2] Financial Metrics - The IPO price of 18.60 yuan per share corresponds to a diluted price-to-earnings (P/E) ratio of 21.68 times, which is lower than the industry average P/E ratio of 68.57 times [3][4] - The average P/E ratio for comparable companies in the electrical machinery and equipment manufacturing industry is 60.25 (before deducting non-recurring gains and losses) and 68.57 (after deducting non-recurring gains and losses) [4] Share Liquidity - After the IPO, the number of freely tradable shares will be 34.28 million, accounting for 19.60% of the total share capital, indicating a potential liquidity risk due to the limited number of circulating shares [3] Contact Information - Legal representative: Guo Zhengping, located at 137 Yun Gu Road, Xinguang Village, Gushan Town, Jiangyin City [5] - Contact person: Guo Wanrong, phone: 0510-68972641 [5]

广东省建筑科学研究院集团股份有限公司 上市公告书 股票简称：广东建科 股票代码：301632 广东省建筑科学研究院集团股份有限公司 Guangdong Provincial Academy of Building Research Group Co., Ltd. （广东省广州市天河区先烈东路 121 号大院） 首次公开发行股票并在创业板上市之 上市公告书 保荐人（主承销商） （深圳市福田区福田街道福华一路 111 号） 二〇二五年八月 广东省建筑科学研究院集团股份有限公司 上市公告书 特别提示 广东省建筑科学研究院集团股份有限公司（以下简称"广东建科""本公司" "发行人"或"公司"）股票将于 2025 年 8 月 12 日在深圳证券交易所创业板上 市。 创业板公司具有业绩不稳定、经营风险高、退市风险大等特点，投资者面临 较大的市场风险。投资者应充分了解创业板市场的投资风险及本公司所披露的风 险因素，审慎做出投资决定。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素，在新 股上市初期切忌盲目跟风"炒新"，应当审慎决策、理性投资。 如无特别说明，本上市公告书中的简称或名词的释义与本公司首次公开发行 ...